Loading…

Artificial intelligence and leukocyte epigenomics: Evaluation and prediction of late-onset Alzheimer's disease

We evaluated the utility of leucocyte epigenomic-biomarkers for Alzheimer's Disease (AD) detection and elucidates its molecular pathogeneses. Genome-wide DNA methylation analysis was performed using the Infinium MethylationEPIC BeadChip array in 24 late-onset AD (LOAD) and 24 cognitively health...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2021-03, Vol.16 (3), p.e0248375-e0248375
Main Authors: Bahado-Singh, Ray O, Vishweswaraiah, Sangeetha, Aydas, Buket, Yilmaz, Ali, Metpally, Raghu P, Carey, David J, Crist, Richard C, Berrettini, Wade H, Wilson, George D, Imam, Khalid, Maddens, Michael, Bisgin, Halil, Graham, Stewart F, Radhakrishna, Uppala
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We evaluated the utility of leucocyte epigenomic-biomarkers for Alzheimer's Disease (AD) detection and elucidates its molecular pathogeneses. Genome-wide DNA methylation analysis was performed using the Infinium MethylationEPIC BeadChip array in 24 late-onset AD (LOAD) and 24 cognitively healthy subjects. Data were analyzed using six Artificial Intelligence (AI) methodologies including Deep Learning (DL) followed by Ingenuity Pathway Analysis (IPA) was used for AD prediction. We identified 152 significantly (FDR p
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0248375